173 related articles for article (PubMed ID: 6182251)
1. Regulation of susceptibility to natural killer cells' cytotoxicity and regulation of HLA synthesis: differing efficacies of alpha, beta, and gamma interferons.
Wallach D
J Interferon Res; 1982; 2(3):329-38. PubMed ID: 6182251
[TBL] [Abstract][Full Text] [Related]
2. Regulation of natural killer cytotoxicity by Escherichia coli-derived human interferon gamma.
Platsoucas CD
Scand J Immunol; 1986 Jul; 24(1):93-108. PubMed ID: 3088722
[TBL] [Abstract][Full Text] [Related]
3. Interferon-induced resistance to the killing by NK cells: a preferential effect of IFN-gamma.
Wallach D
Cell Immunol; 1983 Feb; 75(2):390-5. PubMed ID: 6403252
[TBL] [Abstract][Full Text] [Related]
4. The protective effect of interferon against natural killing activity is not mediated via the expression of class I MHC antigens.
Reiter Z; Fischer DG; Rubinstein M
Immunol Lett; 1988 Apr; 17(4):323-8. PubMed ID: 2453457
[TBL] [Abstract][Full Text] [Related]
5. Effect of interferons on the inhibition of human natural killers by primary monolayer cell cultures.
Heiskala M
Immunology; 1987 Feb; 60(2):167-72. PubMed ID: 2434416
[TBL] [Abstract][Full Text] [Related]
6. Effects of interferons and interleukin 2 on natural killing of cytomegalovirus-infected fibroblasts.
Bandyopadhyay S; Miller DS; Matsumoto-Kobayashi M; Clark SC; Starr SE
Clin Exp Immunol; 1987 Feb; 67(2):372-82. PubMed ID: 2440628
[TBL] [Abstract][Full Text] [Related]
7. Selective impairment of alpha-interferon-mediated natural killer augmentation in Sjögren's syndrome: differential effects of alpha-interferon, gamma-interferon, and interleukin 2 on cytolytic activity.
Takeda A; Minato N; Kano S
Clin Exp Immunol; 1987 Nov; 70(2):354-63. PubMed ID: 2448073
[TBL] [Abstract][Full Text] [Related]
8. Interferon--a major regulator of natural killer cell-mediated cytotoxicity.
Reiter Z
J Interferon Res; 1993 Aug; 13(4):247-57. PubMed ID: 7693829
[TBL] [Abstract][Full Text] [Related]
9. Natural killer cell activity against cultured melanoma cells: a dye-reduction technique with studies on augmented activity by interferon subtypes.
Losinno C; Wines BD; Johns TG; Mackay IR
Nat Immun; 1992; 11(4):215-24. PubMed ID: 1384830
[TBL] [Abstract][Full Text] [Related]
10. Preferential effect of gamma interferon on the synthesis of HLA antigens and their mRNAs in human cells.
Wallach D; Fellous M; Revel M
Nature; 1982 Oct; 299(5886):833-6. PubMed ID: 6290893
[TBL] [Abstract][Full Text] [Related]
11. Natural killer activity in cloned cytotoxic T lymphocytes: regulation by interleukin 2, interferon, and specific antigen.
Brooks CG; Holscher M; Urdal D
J Immunol; 1985 Aug; 135(2):1145-52. PubMed ID: 2409140
[TBL] [Abstract][Full Text] [Related]
12. IFN increases class I MHC antigen expression on adenovirus-infected human cells without inducing resistance to natural killer cell killing.
Routes JM
J Immunol; 1992 Oct; 149(7):2372-7. PubMed ID: 1382100
[TBL] [Abstract][Full Text] [Related]
13. A direct comparison of biological response modulation and clinical side effects by interferon-beta ser, interferon-gamma, or the combination of interferons beta ser and gamma in humans.
Schiller JH; Storer B; Paulnock DM; Brown RR; Datta SP; Witt PL; Borden EC
J Clin Invest; 1990 Oct; 86(4):1211-21. PubMed ID: 2120284
[TBL] [Abstract][Full Text] [Related]
14. Synergistic effects of phorbol ester and interferon-alpha: target cell class I HLA antigen expression and resistance to natural killer and lymphokine-activated killer cell-mediated cytolysis.
Migita K; Eguchi K; Akiguchi I; Ida H; Kawakami A; Ueki Y; Kurata A; Fukuda T; Nagataki S
Cell Immunol; 1991 May; 134(2):325-35. PubMed ID: 2021973
[TBL] [Abstract][Full Text] [Related]
15. Inability of interferon to protect virus-infected cells against lysis by natural killer (NK) cells correlates with NK cell-mediated antiviral effects in vivo.
Bukowski JF; Welsh RM
J Immunol; 1985 Nov; 135(5):3537-41. PubMed ID: 2413125
[TBL] [Abstract][Full Text] [Related]
16. Type I interferons enhance production of IFN-gamma by NK cells.
Hunter CA; Gabriel KE; Radzanowski T; Neyer LE; Remington JS
Immunol Lett; 1997 Oct; 59(1):1-5. PubMed ID: 9334850
[TBL] [Abstract][Full Text] [Related]
17. Interaction of recombinant interferons with recombinant interleukin-2: differential effects on natural killer cell activity and interleukin-2-activated killer cells.
Brunda MJ; Tarnowski D; Davatelis V
Int J Cancer; 1986 May; 37(5):787-93. PubMed ID: 2422129
[TBL] [Abstract][Full Text] [Related]
18. IFN-gamma treatment of K562 cells inhibits natural killer cell triggering and decreases the susceptibility to lysis by cytoplasmic granules from large granular lymphocytes.
Grönberg A; Ferm MT; Ng J; Reynolds CW; Ortaldo JR
J Immunol; 1988 Jun; 140(12):4397-402. PubMed ID: 3131433
[TBL] [Abstract][Full Text] [Related]
19. Recombinant interferons or interleukin-2 increase cytotoxicity by human monocytes and NK cells.
Frey JR; Kamber M; Peck R
Lymphokine Res; 1987; 6(3):215-27. PubMed ID: 3114569
[TBL] [Abstract][Full Text] [Related]
20. Regulation of natural killer cytotoxicity by recombinant alpha interferons. Augmentation by IFN-alpha 7, an interferon similar to IFN-alpha J.
Platsoucas CD; Fox FE; Oleszak E; Fong K; Nanno M; Ioannides CG; Trotta PP
Anticancer Res; 1989; 9(4):849-58. PubMed ID: 2817813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]